Skip to content

Effectiveness of a Lifestyle Intervention on Metabolic Syndrome.

Effectiveness of a Lifestyle Intervention on Metabolic Syndrome. A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03416439
Enrollment
335
Registered
2018-01-31
Start date
2004-09-30
Completion date
2006-02-28
Last updated
2018-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifestyle Intervention

Brief summary

The investigators compared the effectiveness of a lifestyle intervention program carried out by trained professionals versus standard unstructured information on healthy lifestyle given by the family physicians in ameliorating the metabolic pattern of adults with multiple metabolic and inflammatory abnormalities.

Detailed description

Intensive lifestyle intervention significantly reduces the progression to diabetes in high-risk individuals. It is unknown if a less intensive program might also be effective in the general population. The investigators' aim was to compare the effectiveness of two different modalities that recommend a healthier lifestyle to reduce multiple metabolic abnormalities-a lifestyle intervention program with general recommendations carried out by trained professionals and standard unstructured information given by the family physician-in a dysmetabolic population-based cohort. All subjects aged 45-64 (n=1,877) from 6 family physicians, representative of the local Health Districts of Asti (Northern Italy), were contacted. A metabolic screening was carried out on 1,658 subjects (88.3%) who accepted to participate. Out of those subjects, 375 patients had either the metabolic syndrome (MS) or two components of the MS plus high-sensitivity C-reactive protein (CRP) serum values ≥3 mg/L, the cutoff point that differentiates high-risk groups for future cardiovascular events, and did not have any of the exclusion criteria. Then,187 were randomly allocated to the intervention arm and 188 to the control arm; 18 and 22 individuals refused to participate, respectively. Finally, 169 patients were assigned to the lifestyle intervention program carried out by trained professionals (intervention arm) and 166 to the standard, unstructured information given by the family physicians (control arm). All participants received verbal, not-written, information, emphasizing the importance of a healthy lifestyle from their family physicians, who had previously participated in 3 meetings on standard practice lifestyle recommendations. No further individualized programs were offered to the control arm. The intervention arm received detailed verbal and written individualized diet and exercise recommendations from trained professionals during five 60-min sessions covering diet, exercise, and behavior modifications (the first was a one-to-one meeting, the following were group sessions). Anthropometric measurements and blood samples were collected from all participants at the beginning and at the trial end, after 1-year.

Interventions

OTHERlifestyle intervention

lifestyle intervention program carried out by trained professionals

Sponsors

University of Turin, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Lifestyle intervention program carried out by trained professionals versus standard, unstructured information given by the family physicians

Eligibility

Sex/Gender
ALL
Age
45 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Subjects aged 45-64 from 6 family physicians, representative of the local Health Districts of Asti (Northern Italy) * Presence of the metabolic syndrome (MS) or hs-CRP\>3mg/l and 2 components of the MS

Exclusion criteria

* diabetes, cardiovascular diseases, chronic liver or kidney disease, advanced cancer

Design outcomes

Primary

MeasureTime frameDescription
Between-group change in the prevalence of the metabolic syndrome, defined by the National Cholesterol Education Program criteria1 year after randomizationMetabolic syndrome was defined by the National Cholesterol Education Program criteria as the presence of ≥3 of the following five criteria: fasting glucose ≥6.1 mmol/L; blood pressure ≥ 130/85 mmHg; triglycerides ≥1.69 mmol/L; high-density lipoprotein (HDL) cholesterol \<1.29 mmol/L (females) or \<1.04 mmol/L (males), and waist circumference \>88 cm (females) or \>102 cm (males).

Secondary

MeasureTime frame
Within- and between-group variations in weight values1 year after randomization
Within- and between-group variations in fasting glucose1-year after randomization
Within- and between-group variations in arterial blood pressure1 year after randomization
Within- and between-group variations in triglyceride values1-year after randomization
Within- and between-group variations in HDL-cholesterol values1-year after randomization
Within- and between-group variations in C-reactive protein values1-year after randomization

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026